Ultraviolet Germicidal Irradiation Market Size (2024 - 2029)

The ultraviolet germicidal irradiation market is projected to experience significant growth during the forecast period, driven by increased demand for disinfection technologies, particularly in healthcare settings, due to the COVID-19 pandemic. The heightened awareness of the benefits of UVGI for preventing infections has led to a surge in product launches and technological advancements. Additionally, the rising prevalence of hospital-acquired infections and the development of innovative UVGI products are contributing to the expansion of the market. Despite these growth drivers, certain limitations associated with UVGI may pose challenges to the market's expansion.

Home Market Analysis Healthcare Research Medical Devices Research Surgical Devices Research Ablation Devices Research Germicidal Irradiation Market Market Size

Market Size of Ultraviolet Germicidal Irradiation Industry

Ultraviolet Germicidal Irradiation Market Snapshot
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 8.90 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Ultraviolet Germicidal Irradiation Market Major Players

*Disclaimer: Major Players sorted in no particular order

Ultraviolet Germicidal Irradiation Market Analysis

The ultraviolet germicidal irradiation market is expected to register a CAGR of 8.9% during the forecast period.

The COVID-19 pandemic significantly impacted the growth of the ultraviolet germicidal irradiation market due to the increased demand for disinfection of hospitals and diagnostic laboratories to reduce airborne and surface bacterial and viral infections. For instance, according to an ACS Publications article, innovative disinfection technologies, including UV radiation, were found to be of tremendous importance in preventing the transmission of COVID-19 in 2020. The increased use of UVC sterilization equipment for air and surface disinfection was noticed during the pandemic. Due to the pandemic, healthcare organizations are now more aware of the benefits of ultraviolet germicidal disinfection, which led to increased product launches by major companies globally. For instance, in February 2021, Airific Systems developed UVHeal SafeAir, one of India's first UVGI systems, tested and certified by the ICMR-CSIR Virology Lab (CCMB) for 99% disinfection against SARS-CoV-2. The key players exhibit a significant interest in producing and launching new practical UVGI products for current and future pandemics, thereby boosting the growth of the market during the forecast period.

In addition, the increasing prevalence of hospital-acquired infections and technological advancements in ultraviolet germicidal irradiation is actively affecting the growth of the market studied.

According to the WHO, out of every 100 patients in acute-care hospitals, seven in wealthy countries and 15 in low- and middle-income countries were likely to acquire at least one healthcare-associated infection (HAI) during their hospital stay in 2022. This increased demand for technologies that effectively eliminate germs and pathogens. The surge in HAI is projected to boost demand for the ultraviolet germicidal irradiation method of disinfection in healthcare institutions, thereby boosting the growth of the market.

Additionally, the advancements in technology and increasing product approvals, along with partnerships and acquisitions by key players, drive the growth of the market. For instance, in January 2022, Iveda launched its commercial-grade, AI-driven ultraviolet germicidal irradiation (UVGI) product. Iveda Smart UVC vents irradiate all kinds of bacteria and viruses, including COVID-19. By leveraging the existing air circulation system, it disinfects the air by irradiating UV light onto the passing air. This eliminates the need to disinfect offices, meeting rooms, and other workspaces manually. As a result, UVGI technologies have undergone technological advancements, leading to the growth of the market.

Therefore, owing to the abovementioned factors, the market studied is anticipated to witness growth over the forecast period. However, limitations associated with ultraviolet germicidal irradiation (UVGI) are likely to impede the growth of the market.

Ultraviolet Germicidal Irradiation Industry Segmentation

Ultraviolet germicidal irradiation (UVGI) is a disinfection method that uses UVC light to inactivate microorganisms by disrupting their DNA, which is used in cleaning hospital rooms, operating rooms, research facilities, and laboratories. 

The Ultraviolet Germicidal Irradiation Market is segmented by Type (Air Disinfectant, Surface Disinfectant, Other Types), End User (Hospitals and Surgical Centers, Research Laboratories, Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report provides the market sizes and forecasts in terms of value in USD million.

By Type
Air Disinfectant
Surface Disinfectant
Other Types
By End User
Hospitals and Surgical Centers
Research Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Ultraviolet Germicidal Irradiation Market Size Summary

The ultraviolet germicidal irradiation (UVGI) market is poised for significant growth, driven by the heightened awareness and demand for disinfection solutions following the COVID-19 pandemic. The pandemic underscored the importance of UVGI technologies in preventing the spread of airborne and surface infections, leading to increased adoption in healthcare settings. This surge in demand has prompted major companies to innovate and launch new UVGI products, enhancing their capabilities to combat pathogens effectively. The market is further bolstered by the rising prevalence of hospital-acquired infections and technological advancements in UVGI systems, which are becoming integral in healthcare institutions to ensure sterile environments. The introduction of AI-driven and automated UVGI solutions is also contributing to the market's expansion, as these technologies offer efficient and effective disinfection without manual intervention.

North America is expected to lead the UVGI market, supported by a robust healthcare infrastructure, increased awareness of infection control technologies, and a strong presence of key industry players. The region's growing incidence of chronic diseases necessitates extended hospital stays, thereby amplifying the need for effective disinfection solutions. Technological advancements, product launches, and strategic collaborations among key players are anticipated to further propel market growth in North America. The competitive landscape is characterized by a few dominant companies, both globally and regionally, which continue to innovate and expand their product offerings. These developments, coupled with the ongoing demand for UVGI technologies in various settings, are expected to drive the market's growth trajectory over the forecast period.

Explore More

Ultraviolet Germicidal Irradiation Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Hospital-acquired Infection

      2. 1.2.2 Technological Advancements in Ultraviolet Germicidal Irradiation

    3. 1.3 Market Restraints

      1. 1.3.1 Limitations Associated with Ultraviolet Germicidal Irradiation (UVGI)

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size in Value - USD million)

    1. 2.1 By Type

      1. 2.1.1 Air Disinfectant

      2. 2.1.2 Surface Disinfectant

      3. 2.1.3 Other Types

    2. 2.2 By End User

      1. 2.2.1 Hospitals and Surgical Centers

      2. 2.2.2 Research Laboratories

      3. 2.2.3 Other End Users

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Ultraviolet Germicidal Irradiation Market Size FAQs

The Ultraviolet Germicidal Irradiation Market is projected to register a CAGR of 8.90% during the forecast period (2024-2029)

American Ultraviolet, Atlantic Ultraviolet Corporation, Ensavior, Koninklijke Philips N.V. and UltraViolet Devices, Inc. are the major companies operating in the Ultraviolet Germicidal Irradiation Market.

Ultraviolet Germicidal Irradiation Market Report Snapshots

Ultraviolet Germicidal Irradiation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)